Evidence map›Paper›PMID 35742875›Full record

ArticleInternational journal of molecular sciences2022

Beneficial Effects of O-GlcNAc Stimulation in a Young Rat Model of Sepsis: Beyond Modulation of Gene Expression.

Thomas Dupas, Antoine Persello, Angélique Blangy-Letheule, Manon Denis, Angélique Erraud, Virginie Aillerie, Aurélia A Leroux, Matthieu Rivière, Jacques Lebreton, Arnaud Tessier and 2 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 2 pooled it
1.0field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 2 syntheses or guidelines pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Thomas DupasNantes Université, CHU Nantes, CNRS, INSERM, l'institut du thorax, F-44000 Nantes, France.ORCID 0000-0002-8827-3526
Antoine PerselloNantes Université, CHU Nantes, CNRS, INSERM, l'institut du thorax, F-44000 Nantes, France.
Angélique Blangy-LetheuleNantes Université, CHU Nantes, CNRS, INSERM, l'institut du thorax, F-44000 Nantes, France.
Manon DenisNantes Université, CHU Nantes, CNRS, INSERM, l'institut du thorax, F-44000 Nantes, France.ORCID 0000-0002-1081-7829
Angélique ErraudNantes Université, CHU Nantes, CNRS, INSERM, l'institut du thorax, F-44000 Nantes, France.ORCID 0000-0002-5962-215X
Virginie AillerieNantes Université, CHU Nantes, CNRS, INSERM, l'institut du thorax, F-44000 Nantes, France.
Aurélia A LerouxNantes Université, CHU Nantes, CNRS, INSERM, l'institut du thorax, F-44000 Nantes, France.ORCID 0000-0002-0877-0451
Matthieu RivièreNantes Université, CNRS, CEISAM, UMR 6230, F-44000 Nantes, France.ORCID 0000-0001-7987-9457
Jacques LebretonNantes Université, CNRS, CEISAM, UMR 6230, F-44000 Nantes, France.ORCID 0000-0003-2603-8982
Arnaud TessierNantes Université, CNRS, CEISAM, UMR 6230, F-44000 Nantes, France.ORCID 0000-0001-7053-2203
Bertrand RozecNantes Université, CHU Nantes, CNRS, INSERM, l'institut du thorax, F-44000 Nantes, France.
Benjamin LauzierNantes Université, CHU Nantes, CNRS, INSERM, l'institut du thorax, F-44000 Nantes, France.ORCID 0000-0002-1370-6155
Centre National de la Recherche Scientifique · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The young population, which is particularly at risk of sepsis, is, paradoxically, rarely studied. Acute stimulation of O-GlcNAcylation, a post-translational modification involved in metabolic regulation, cell survival and stress response, is beneficial in young rats with sepsis. Considering that sepsis impacts the gene expression profile and that O-GlcNAcylation is a regulator of transcription, the aims of this study are to (i) unveil beneficial mechanisms of O-GlcNAcylation and (ii) decipher the relationship between O-GlcNAcylation and transcription during sepsis. Endotoxemic challenge was induced in 28-day-old male rats using a lipopolysaccharide injection (E. coli O111:B4, 20 mg·kg−1) and compared to control rats (NaCl 0.9%). One hour after, rats were assigned to no therapy or fluidotherapy (NaCl 0.9%, 10 mL.kg−1) ± NButGT (10 mg·kg−1) to stimulate O-GlcNAc levels. Cardiac O-GlcNAcylation levels were evaluated via Western blot and gene transcription using 3′ SRP analysis. Lipopolysaccharide injection favorizes inflammatory state with the overexpression of genes involved in the NF-κB, JAK/STAT and MAPK pathways. NButGT treatment increased cardiac O-GlcNAcylation levels (p < 0.05). Yet, the mRNA expression was not impacted two hours after fluidotherapy or NButGT treatment. In conclusion, O-GlcNAc stimulation-induced beneficial effects are not dependent on the gene expression profile at the early phase of sepsis.

Indexed as

LipopolysaccharidesSepsisAcetylglucosamineAnimalsEscherichia coliGene ExpressionMaleN-AcetylglucosaminyltransferasesProtein Processing, Post-TranslationalRatsSodium ChlorideAcetylglucosamineLipopolysaccharidesN-AcetylglucosaminyltransferasesSodium Chloridegene expressionO-GlcNAcylationpost-translational modificationsepsistherapeutic strategytranscriptomic

Identifiers

PMID35742875
PMCPMC9224386
OpenAlexW4281631142

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.